Suppr超能文献

干扰素α2a通过PI3激酶和丝裂原活化蛋白激酶信号通路下调血管内皮生长因子(VEGF)的表达。

Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways.

作者信息

Wu Wei-Zhong, Sun Hui-Chuan, Shen Yue-Fang, Chen Jie, Wang Lu, Tang Zhao-You, Iliakis George, Liu Kang-Da

机构信息

Liver Cancer Institute and Zhongshan Hospital, Fudan University, 136 Yi Xue Yuan Road, 200032 Shanghai, P.R.China.

出版信息

J Cancer Res Clin Oncol. 2005 Mar;131(3):169-78. doi: 10.1007/s00432-004-0615-2. Epub 2004 Dec 11.

Abstract

An earlier report demonstrated that interferon alpha (IFN-alpha) inhibited tumor growth and recurrence in an MHCC97 xenograft model in nude mice by suppressing tumor angiogenesis rather than by inhibiting tumor cell proliferation. However, the underlying molecular mechanism was not fully elucidated. In this study, we demonstrated that IFN-alpha 2a could down-regulate VEGF expression both in mRNA and in protein levels, as well as down-regulating HIF-1 alpha mRNA expression in MHCC97 cells in vitro. A cDNA micro array analysis followed by Northern and Western blot analysis revealed that PI3 kinase and MAP kinase signaling pathways might be inhibited by IFN-alpha 2a. Blocking the function of IFN-alpha receptor with a specific peptide could eliminate the inhibitory effects of IFN-alpha 2a on VEGF expression. In addition, wortmannin and PD098059, respective inhibitors of the PI3 kinase and the MAP kinase signaling pathways, when used independently or in combination, could also down-regulate the VEGF synthesis and secretion in a similar pattern of IFN-alpha 2a. These observations may lead to the conclusion that IFN-alpha 2a could suppress VEGF synthesis and secretion by down-regulating HIF-1 alpha expression, via inhibition of the PI3 kinase and/or the MAP kinase signaling pathways.

摘要

较早的一份报告表明,α干扰素(IFN-α)通过抑制肿瘤血管生成而非抑制肿瘤细胞增殖,抑制了裸鼠MHCC97异种移植模型中的肿瘤生长和复发。然而,其潜在的分子机制尚未完全阐明。在本研究中,我们证明IFN-α 2a在体外可下调MHCC97细胞中VEGF的mRNA和蛋白水平表达,以及下调HIF-1α mRNA表达。随后进行的cDNA微阵列分析以及Northern和Western印迹分析显示,PI3激酶和MAP激酶信号通路可能受到IFN-α 2a的抑制。用特异性肽阻断IFN-α受体的功能可消除IFN-α 2a对VEGF表达的抑制作用。此外,PI3激酶和MAP激酶信号通路的各自抑制剂渥曼青霉素和PD098059单独使用或联合使用时,也能以与IFN-α 2a类似的模式下调VEGF的合成和分泌。这些观察结果可能得出结论,IFN-α 2a可通过抑制PI3激酶和/或MAP激酶信号通路,下调HIF-1α表达,从而抑制VEGF的合成和分泌。

相似文献

1
Interferon alpha 2a down-regulates VEGF expression through PI3 kinase and MAP kinase signaling pathways.
J Cancer Res Clin Oncol. 2005 Mar;131(3):169-78. doi: 10.1007/s00432-004-0615-2. Epub 2004 Dec 11.
2
Octreotide acts as an antitumor angiogenesis compound and suppresses tumor growth in nude mice bearing human hepatocellular carcinoma xenografts.
J Cancer Res Clin Oncol. 2003 Jun;129(6):327-34. doi: 10.1007/s00432-003-0447-5. Epub 2003 Jun 14.
4
Interferon-alpha 2a up-regulated thymidine phosphorylase and enhanced antitumor effect of capecitabine on hepatocellular carcinoma in nude mice.
J Cancer Res Clin Oncol. 2004 Sep;130(9):546-50. doi: 10.1007/s00432-004-0565-8. Epub 2004 Apr 8.
6
Oroxylin A inhibits angiogenesis through blocking vascular endothelial growth factor-induced KDR/Flk-1 phosphorylation.
J Cancer Res Clin Oncol. 2010 May;136(5):667-75. doi: 10.1007/s00432-009-0705-2. Epub 2009 Nov 4.
7
Systemic treatments for metastatic cutaneous melanoma.
Cochrane Database Syst Rev. 2018 Feb 6;2(2):CD011123. doi: 10.1002/14651858.CD011123.pub2.
8
Bevacizumab enhances chemosensitivity of hepatocellular carcinoma to adriamycin related to inhibition of survivin expression.
J Cancer Res Clin Oncol. 2011 Mar;137(3):505-12. doi: 10.1007/s00432-010-0914-8. Epub 2010 May 21.
10
Downregulation of Raf-1 kinase inhibitory protein as a sorafenib resistance mechanism in hepatocellular carcinoma cell lines.
J Cancer Res Clin Oncol. 2018 Aug;144(8):1487-1501. doi: 10.1007/s00432-018-2672-y. Epub 2018 Jun 1.

引用本文的文献

1
CXCL10 promotes melanoma angiogenesis and tumor growth.
Anim Cells Syst (Seoul). 2024 Sep 11;28(1):453-465. doi: 10.1080/19768354.2024.2402024. eCollection 2024.
4
The role of microenvironment in tumor angiogenesis.
J Exp Clin Cancer Res. 2020 Sep 30;39(1):204. doi: 10.1186/s13046-020-01709-5.
5
Thrombotic microangiopathy caused by interferon β-1b for multiple sclerosis: a case report.
CEN Case Rep. 2016 Nov;5(2):179-183. doi: 10.1007/s13730-016-0220-7. Epub 2016 Jun 20.
6
Anti-VEGFR2-interferon-α2 regulates the tumor microenvironment and exhibits potent antitumor efficacy against colorectal cancer.
Oncoimmunology. 2017 Feb 17;6(3):e1290038. doi: 10.1080/2162402X.2017.1290038. eCollection 2017.
7
Chemotherapeutic agents for the treatment of hepatocellular carcinoma: efficacy and mode of action.
Oncol Rev. 2014 May 28;8(1):246. doi: 10.4081/oncol.2014.246. eCollection 2014 Mar 17.
8
Interferon-α enhances the susceptibility of renal cell carcinoma to rapamycin by suppressing mTOR activity.
Exp Ther Med. 2014 Jul;8(1):267-273. doi: 10.3892/etm.2014.1691. Epub 2014 Apr 25.
9
Targeting the endothelin axis with atrasentan, in combination with IFN-alpha, in metastatic renal cell carcinoma.
Br J Cancer. 2012 Jan 17;106(2):284-9. doi: 10.1038/bjc.2011.515. Epub 2012 Jan 3.

本文引用的文献

5
Different effects of glucose starvation on expression and stability of VEGF mRNA isoforms in murine ovarian cancer cells.
Biochem Biophys Res Commun. 2002 Apr 12;292(4):860-8. doi: 10.1006/bbrc.2002.6710.
7
Cytotoxicity of IFN-gamma and TNF-alpha for vascular endothelial cell is mediated by nitric oxide.
Biochem Biophys Res Commun. 2002 Mar 8;291(4):780-6. doi: 10.1006/bbrc.2002.6487.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验